Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00078390 · ClinicalTrials.gov registry record · Phase 1
Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer
A Phase 1 study of Non-Small Cell Lung Cancer and Lung Cancer, sponsored by Shionogi.
- Completed
- Registry status
- Phase 1
- Development phase
- 9
- Enrollment target
- 5
- Study locations
NCT00078390 is a Phase 1 study of Non-Small Cell Lung Cancer and Lung Cancer that has completed, run by Shionogi. The registered enrollment target is 9 participants, below the 659-participant average among 449 other Non-Small Cell Lung Cancer trials with a reported enrollment target (99% lower). The trial reports 5 study locations across 5 states.
The verdict
NCT00078390, a Phase 1 study of Non-Small Cell Lung Cancer and Lung Cancer, has completed, sponsored by Shionogi.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 9 participants
- Enrollment target
- 5
- Study locations
Study Summary
A study to measure the safety and effectiveness of S-3304 when given in combination with conventional chemo-radiation therapy in patients with locally advanced non-small cell lung cancer.
Conditions Studied
Interventions
- DRUG S-3304
- OTHER Chemo-irradiation
Study Locations (5)
California
- Scripps Cancer Institute - La Jolla
District of Columbia
- Lombardi Cancer Center - Washington D.C.
Kansas
- University of Kansas Cancer Center - Kansas City
New Jersey
- VA Medical Center-East Orange (study available to veterans only) - East Orange
Ohio
- The Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2003-02 |
| Est. Completion | 2006-10-26 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00078390
The ClinicalTrials.gov registry entry for NCT00078390 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 659-participant average among 449 other Non-Small Cell Lung Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Shionogi, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 2 interventions - of which S-3304 is the first listed.
NCT00078390 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, District of Columbia, Kansas.
Frequently Asked Questions
What is clinical trial NCT00078390 about?
NCT00078390 is a clinical study titled "Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer". A study to measure the safety and effectiveness of S-3304 when given in combination with conventional chemo-radiation therapy in patients with locally advanced non-small cell lung cancer.
What is the current status of trial NCT00078390?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 9 participants. The study started on 2003-02. Estimated completion is 2006-10-26.
What conditions does trial NCT00078390 study?
This clinical trial studies the following conditions: Non-Small Cell Lung Cancer, Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IIIA Non-Small Cell Lung Cancer.
What interventions are being tested in trial NCT00078390?
The interventions under investigation include: S-3304 (DRUG), Chemo-irradiation (OTHER).
Who is sponsoring clinical trial NCT00078390?
This trial is sponsored by Shionogi, which has 54 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00078390 being conducted?
This trial has 5 study locations across California, District of Columbia, Kansas, New Jersey, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Small Cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RECRUITING · Phase 1
-
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
RECRUITING · Phase 1
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
RECRUITING · Phase 1
-
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.